Werkgroep Cardiologische centra Nederland English

THEMIS (Follow up)

A multinational, randomised, double-blind, placebo-controlled trial to evaluate the effect of ticagrelor 90mg twice daily on the incidence of cardiovascular death, myocardial infarction or stroke in patients with type 2 diabetes mellitus

Middel
ticagrelor
Populatie
preventie (diabetes)
Fase
III
Jaar aanvang
2015
Meer informatie
ClinicalTrials.gov

Studiedirecteur

dr. S.H.K. The (Cardioloog)
Hoogeveen, Treant Zorggroep